Resources from the same session
Welcome and Introductions
Presenter: Josep Tabernero
Session: Pierre Fabre Laboratories - Precision oncology for BRAF mutant cancers
Resources:
Webcast
BRAF as a breakthrough in the treatment of BRAFV600-mutant metastatic melanoma
Presenter: Axel Hauschild
Session: Pierre Fabre Laboratories - Precision oncology for BRAF mutant cancers
Resources:
Webcast
Same strategy, different challenge: Managing BRAFV600 disease in advanced NSCLC
Presenter: Gregory Riely
Session: Pierre Fabre Laboratories - Precision oncology for BRAF mutant cancers
Resources:
Webcast
Different strategy, same target: Managing BRAFV600E-mutant metastatic colorectal cancer
Presenter: Chiara Cremolini
Session: Pierre Fabre Laboratories - Precision oncology for BRAF mutant cancers
Resources:
Webcast
Interactive, case-based panel discussion: Optimal care of patients receiving treatment with BRAF-targeted agents (Case Study 1)
Presenter: Gregory Riely
Session: Pierre Fabre Laboratories - Precision oncology for BRAF mutant cancers
Resources:
Webcast
What's next for this target?
Presenter: Josep Tabernero
Session: Pierre Fabre Laboratories - Precision oncology for BRAF mutant cancers
Resources:
Webcast